White Paper

Tarzana Treatment Centers

Tarzana Treatment Centers’ six primary care clinics serve more than 1,200 patients diagnosed with diabetes living in the greater Los Angeles area. In September 2022, all six clinics moved their eyecare management for people with diabetes from remote reading networks to autonomous AI with LumineticsCore™ (formerly IDx-DR).

Patients are empowered when they see how their retina looks and what a worse outcome prognosis could be. In this case, the patient was so motivated to not lose his sight that he dropped his HbA1c within three months. We are now discussing decreasing daily insulin dosages. - Provider Overseeing Diabetes Care

LumineticsCore’s autonomous AI helps improve rates of annual eye exams for diabetes (EED), reduces time-to-follow-up and improves patient outcomes in a complex population. In nine months, rates for eye exams for diabetes improved from 25% with a remote reading network to 71% with autonomous AI at one clinic.

View the Tarzana Treatment Centers - White Paper

Notice: The content embedded within PDF files on this website ("Content") is provided solely for educational purposes. Digital Diagnostics ("Owner") holds exclusive rights to the Content, including but not limited to copyrights, trademarks, and any other intellectual property rights.

White Papers / Position Papers | April 21, 2023

Tarzana Treatment Centers White Paper